SCHEMBL667814

SCHEMBL667814

[CH2]Cc1ccccc1CCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 1/20 0.58
▸ THRA P10827 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ NR1H2 P55055 1/20 0.47
▸ NR1H3 Q13133 1/20 0.47
▸ BID P55957 3/20 0.45
▸ MCL1 Q07820 3/20 0.45
▸ BCL2L1 Q07817 2/20 0.45
▸ BAK1 Q16611 2/20 0.45
▸ KAT8 Q9H7Z6 2/20 0.45
▸ PPARG P37231 1/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ EP300 Q09472 1/20 0.45
▸ KAT2A Q92830 1/20 0.45
▸ KAT2B Q92831 1/20 0.45
▸ KAT5 Q92993 1/20 0.45
▸ SAE1 Q9UBE0 1/20 0.45
▸ KCNH2 Q12809 1/20 0.44
▸ ALOX5 P09917 2/20 0.43
▸ PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL677574 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL9386103 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL2919197 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL677130 0.98 LIPG (0.55) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL482780 0.91 LIPG (0.47) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL11393854 0.91 LIPG (0.67) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL269513 0.89 LIPG (0.69) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL3849327 0.89 LIPG (0.69) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL10758354 0.89 LIPG (0.69) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL271030 0.89 LIPG (0.69) LIPGTHRATHRBNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999014204-A1 SUBSTITUTED 1,2,4-TRIAZOLES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY G.D. SEARLE & CO. (US) 1999-03-25 — — WO claimed
US-10583115-B2 Modulators of 14-3-3 functionality and uses thereof UNIVERSITY OF SOUTH AUSTRALIA (AU) 2020-03-10 — — US disclosed
US-20170312249-A1 MODULATORS OF 14-3-3 FUNCTIONALITY AND USES THEREOF UNIVERSITY OF SOUTH AUSTRALIA (AU) 2017-11-02 — — US disclosed
WO-2016054680-A1 MODULATORS OF 14-3-3 FUNCTIONALITY AND USES THEREOF UNIVERSITY OF SOUTH AUSTRALIA (AU) 2016-04-14 — — WO disclosed
US-9090722-B2 Chemical amplification resist composition, and mold preparation method and resist film using the same FUJIFILM CORPORATION (JP) 2015-07-28 — — US disclosed
EP-1367439-B1 Radiation-sensitive composition FUJIFILM CORP (JP) 2012-08-01 — — EP disclosed
US-8192373-B2 Medical guide wire and process for production thereof SEVEN DREAMERS LABORATORIES, INC. (US) 2012-06-05 — — US disclosed
US-20120006788-A1 CHEMICAL AMPLIFICATION RESIST COMPOSITION, AND MOLD PREPARATION METHOD AND RESIST FILM USING THE SAME FUJIFILM CORPORATION (JP) 2012-01-12 — — US disclosed
EP-2399168-A1 CHEMICAL AMPLIFICATION RESIST COMPOSITION, AND MOLD PREPARATION METHOD AND RESIST FILM USING THE SAME FUJIFILM Corporation (JP) 2011-12-28 — — EP disclosed
WO-2010150917-A1 CHEMICAL AMPLIFICATION RESIST COMPOSITION, AND MOLD PREPARATION METHOD AND RESIST FILM USING THE SAME FUJIFILM CORPORATION (JP) 2010-12-29 — — WO disclosed
US-20040033437-A1 Radiation-sensitive composition FUJI PHOTO FILM CO., LTD. 2004-02-19 — — US disclosed
US-6692883-B2 GENERATING ACID; ADJUSTMENT SOLUBILITY IN ALKLAINE DEVELOPER FUJI PHOTO FILM CO., LTD. (JP) 2004-02-17 — — US disclosed
EP-1367439-A1 Radiation-sensitive composition FUJI PHOTO FILM CO., LTD. (JP) 2003-12-03 — — EP disclosed
US-6630280-B1 Resin and compound that generates an arylsulfonic acid when exposed to actinic radiation; sensitivity; resolution; smoothness FUJI PHOTO FILM CO., LTD. (JP) 2003-10-07 — — US disclosed
US-20030134221-A1 Positive resist composition FUJI PHOTO FILM CO., LTD. 2003-07-17 — — US disclosed
US-20030108811-A1 Positive resist composition FUJI PHOTO FILM CO., LTD. 2003-06-12 — — US disclosed
US-20020012866-A1 Positive photoresist composition FUJIFILM CORPORATION (JP) 2002-01-31 — — US disclosed
US-6207343-B1 RESIN CONTAINING GROUPS WHICH DECOMPOSE BY THE ACTION OF AN ACID TO ENHANCE ITS SOLUBILITY IN AN ALKALINE DEVELOPING SOLUTION AND A COMPOUND WHICH GENERATES AN ACID UPON IRRADIATION WITH ACTINIC RAYS OR RADIATION FUJI PHOTO FILM CO., LTD. (JP) 2001-03-27 — — US disclosed
US-5944650-A PHOSPHOROUS MODIFIED POLYOXYETHYLENE GLYCOL XEROX CORPORATION (US) 1999-08-31 — — US disclosed
EP-0913459-A1 Surfactants Xerox Corporation (US) 1999-05-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10583115-B2 Modulators of 14-3-3 functionality and uses thereof YWHAH, YWHAG, YWHAB LIPG 1614/4885THRA 3937/4885THRB 3568/4885
US-20170312249-A1 MODULATORS OF 14-3-3 FUNCTIONALITY AND USES THEREOF YWHAH, YWHAG, YWHAB LIPG 1614/4885THRA 3937/4885THRB 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback